Startseite › Hirntumore › Texas › Houston
Klinische Studien zu Hirntumore in Houston, TX
35 Studien zu Hirntumore suchen Teilnehmer an Standorten in und um Houston (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Teilnehmer gesuchtPhase 1
- Baylor St. Luke's Medical Center, Houston
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Teilnehmer gesuchtPhase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Teilnehmer gesuchtPhase 1/2
- MD Anderson Cancer Center, Houston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Teilnehmer gesuchtPhase 2
- Local Institution - 0085, Houston
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Teilnehmer gesuchtPhase 2
- Texas Children's Hospital, Houston
OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Teilnehmer gesuchtBeobachtungsstudie
- M D Anderson Cancer Center, Houston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center - University of Texas, Houston
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
Teilnehmer gesuchtBeobachtungsstudie
- MD Anderson Cancer Center, Houston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Teilnehmer gesuchtPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Teilnehmer gesuchtBeobachtungsstudie
- Texas Children's Hospital, Houston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Teilnehmer gesuchtPhase 2
- UT MD Anderson Cancer Center, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Teilnehmer gesuchtPhase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Teilnehmer gesuchtPhase 2
- Texas Children's Hospital, Houston
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Teilnehmer gesuchtPhase 2
- MD Anderson Cancer Center, Houston
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
Teilnehmer gesuchtPhase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Teilnehmer gesuchtPhase 2
- Houston Methodist Neal Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Teilnehmer gesuchtPhase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Teilnehmer gesuchtPhase 1
- Texas Children's Hospital, Houston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Teilnehmer gesuchtBeobachtungsstudie
- Baylor St. Luke's Medical Center | Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
Teilnehmer gesuchtPhase 1
- M D Anderson Cancer Center, Houston
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
Mapping of Human Cognition
Teilnehmer gesucht
- The University of Texas Health Science Center at Houston, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Teilnehmer gesuchtPhase 2
- Texas Children's Hospital, Houston
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Teilnehmer gesucht
- M D Anderson Cancer Center, Houston
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Teilnehmer gesuchtBeobachtungsstudie
- M D Anderson Cancer Center, Houston
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
Teilnehmer gesuchtPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Teilnehmer gesuchtPhase 1/2
- MD Anderson Cancer Center, Houston
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Teilnehmer gesuchtBeobachtungsstudie
- Md Anderson Cancer Center, Houston
Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)
Teilnehmer gesuchtPhase 2
- M D Anderson Cancer Center, Houston
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Teilnehmer gesucht
- MD Anderson Cancer Center, Houston
Systematic Light Exposure in Pediatric Brain Tumor Survivors
Teilnehmer gesucht
- Texas Children's Hospital, Houston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
Teilnehmer gesuchtPhase 1/2
- MD Anderson, Houston
Hirntumore-Studien in anderen Städten
- Boston, MA28 Studien
- New York City, NY25 Studien
- Washington, DC20 Studien
- Los Angeles, CA16 Studien
- Miami, FL15 Studien
- Durham, NC14 Studien
- St. Louis, MO12 Studien
- Cleveland, OH11 Studien
- Seattle, WA11 Studien
- Rochester, MN11 Studien
- Baltimore, MD11 Studien
- Columbus, OH11 Studien
Weitere Studien in Houston
- Nichtkleinzelliges Lungenkarzinom145 Studien
- Brustkrebs126 Studien
- Krebs (alle Arten)121 Studien
- Metastasierender Krebs104 Studien
- Kolorektales Karzinom102 Studien
- Eierstockkrebs89 Studien
- Akute myeloische Leukämie85 Studien
- Lungenkrebs78 Studien
- Prostatakrebs76 Studien
- Endometriumkarzinom68 Studien
- Bauchspeicheldrüsenkrebs61 Studien
- Melanom59 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.